Although viral load is an important tool for HIV monitoring and the 2016 WHO Consolidated ART guidelines suggest the phasing out of CD4 testing as a tool to assess ART eligibility, the use of CD4 testing in limited resource countries may still be used to prioritize patients in most need ART initiation, to monitor disease progression and opportunistic infections [3]. Here, CD4 is linked to Opportunistic infection.